Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gary Crocker Insider Profile
32 Followers
Gary Crocker, Chairman, President, and Treasurer, Director at Merrimack Pharmaceuticals, holds 133.10K shares in Merrimack Pharmaceuticals (Ticker: MACK). Most recently, Gary Crocker Bought $4,000 shares of Merrimack Pharmaceuticals on Aug 14, 2023 for an estimated value of 49.88K.
Gary Crocker Merrimack Pharmaceuticals (MACK)Chairman, President, and Treasurer, Director
Merrimack Pharmaceuticals (MACK)
Chairman, President, and Treasurer, Director
Ranked #1,250 out of 98,042 Corporate Insiders
Profitable Transactions
9 out of 10 Profitable Transactions
Average Return
+59.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Gary Crocker does not currently own shares as a corporate insider.
A breakdown of Gary Crocker's holdings
Insider Roles
Gary Crocker does not currently hold a role as a corporate insider.
Roles that Gary Crocker holds in companies
Most Profitable Insider Trade
Stock:
Merrimack Pharmaceuticals
(MACK)
(MACK)
Rating:Informative Buy
Date:Mar 14, 2014 - Mar 14, 2015
Return:+109.40%
The most profitable trade made by Gary Crocker
Gary Crocker's Trading History
List of latest transactions for each holding click on a transaction to see Gary Crocker's performance on stock
You May Also Like
Gary Crocker insider profile FAQ
What is the percentage of profitable transactions made by Gary Crocker?
The percentage of profitable transactions made by Gary Crocker is 90%.
What is the average return per transaction made by Gary Crocker?
The average return per transaction made by Gary Crocker is 59.20%.
What stocks does Gary Crocker hold?
Gary Crocker holds: MACK stocks.
What was Gary Crocker’s latest transaction?
Gary Crocker latest transaction was an Informative Buy of $49.88K.
What was Gary Crocker's most profitable transaction?
Gary Crocker’s most profitable transaction was an Informative Buy of MACK stock on March 14, 2014. The return on the trade was 109.40%.
What is Gary Crocker's role in Merrimack Pharmaceuticals?
Gary Crocker's role in Merrimack Pharmaceuticals is Chairman, President, and Treasurer, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.